首页> 外文OA文献 >Adherence to oral anticancer drugs (OAD) in patients with metastatic renal cancer (mRCC): interim results of the prospective observational multicenter IPSOC study (Investigating Patient Satisfaction with Oral antiCancer Treatment)

【2h】

Adherence to oral anticancer drugs (OAD) in patients with metastatic renal cancer (mRCC): interim results of the prospective observational multicenter IPSOC study (Investigating Patient Satisfaction with Oral antiCancer Treatment)

机译：转移性肾癌（mRCC）患者坚持口服抗癌药物（OAD）：前瞻性观察性多中心IPSOC研究的中期结果（调查患者对口服抗癌治疗的满意度）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Wolter Pascal; Debruyne Philip; Hendrickx Tine; Renard Vincent; Mebis Jeroen; Rottey Sylvie; Schallier Denis; Wynendaele Wim; Vermeij Joanna; Nielander Aldrik; Goeminne Jean-Charles; Delande Stephanie; Machiels Jean-Pascal; Schöffski Patrick; De Coster Sandra; Lacour Valerie; Foulon Veerle;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Adherence and Patients' Attitudes to Oral Anticancer Drugs: A Prospective Series of 201 Patients Focusing on Targeted Therapies [J] . Barthelemy Philippe, Asmane-De la Porte Irene, Meyer Nicolas, Oncology: International Journal of Cancer Research and Treatment . 2015,第1期

机译：口服抗癌药物的依从性和患者态度：前瞻性研究201例针对靶向治疗的患者
2. 1258 ORAL Renal insufficiency in cancer patients: Prevalence and implications for anticancer drugs management. preliminary results of the “IRMA” study [J] . European Journal of Cancer Supplements . 2005,第2期

机译：1258口腔癌患者的肾功能不全：患病率及其对抗癌药物管理的意义。 “ IRMA”研究的初步结果
3. Nationwide prevalence of potential drug-drug interactions associated with non-anticancer agents in patients on oral anticancer agents in South Korea [J] . Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer . 2020,第8期

机译：韩国口服抗癌剂与非抗癌剂相关的潜在药物 - 药物相互作用的普遍性
4. Novel polycationic nanocapsules as vehicles for oral anticancer drug delivery [C] . G.Lollo, M. Garcia-Fuentes, D. Torres, Annual meeting exposition of the Controlled Release Society . 2010

机译：新型聚阳离子纳米胶囊作为口服抗癌药物的载体
5. Physicochemical charaterization of the anticancer drug camptothecin in acidic environment and design of oral sustained release formulation using hydrophilic polymer NA-CMC. [D] . Patel, Sanjay. 2008

机译：酸性环境中抗癌药物喜树碱的理化特性和使用亲水性聚合物NA-CMC的口服缓释制剂的设计。
6. Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods [O] . Aurélie Bourmaud, Emilie Henin, Fabien Tinquaut, 2015

机译：坚持口服抗癌化疗：是什么影响患者过度或不坚持？通过定量定性方法对OCTO研究进行分析
7. PCN75 ESTIMATED COSTS OF HER2-POSITIVE METASTATIC BREAST CANCER FOR PATIENTS INITIATING AN ORAL ANTICANCER TREATMENT: RESULTS FROM A FRENCH PROSPECTIVE OBSERVATIONAL STUDY [O] . Woronoff-Lemsi M.C., Chaix-Couturier C., Durand-Zaleski I., 2013

机译：PCN75估计的HER2阳性转移性乳腺癌患者开始口服抗癌药的费用：来自法国的预期观察研究结果

Adherence to oral anticancer drugs (OAD) in patients with metastatic renal cancer (mRCC): interim results of the prospective observational multicenter IPSOC study (Investigating Patient Satisfaction with Oral antiCancer Treatment)

著录项

引文网络

相似文献

相关主题

期刊订阅